👉 Biotech startups are built on progress. New data, stronger validation, deeper insight into the biology. Every week brings movement in the lab, and every milestone feels like a step forward. Yet many founders experience a strange disconnect. Science advances, but funding momentum does not. The pipeline improves, but strategic leverage does not expand. The team works intensely, yet the company does not feel closer to its next inflection point. 👉 At some stage, the uncomfort